TNXP Stock Analysis: Buy, Sell, or Hold?
TNXP - Tonix Pharmaceuticals Holding Corp.
$17.24
-0.98 (-5.38%)
▼
5d:
-5.9%
30d:
+8.98%
90d:
-7.16%
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 17, 2026
Smart Money Accumulation
TNXP is down 5.9% this week, but smart money is accumulating calls. Top strike: $25 2026-03-20 with 263 OI. Call ratio: 85% View Scanner →
Strength: 6.4/10
Get Alerted When TNXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
13 traders called TNXP this week
89% bullish • 2 bearish
89% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TNXP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TNXP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TNXP is currently trading at $17.24, which is considered fair relative to its 30-day fair value range of $15.53 to $17.91.
Technical Outlook: Technically, TNXP is in a strong downtrend. Immediate support is located at $15.74, while resistance sits at $19.95. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: TNXP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (9th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $67.67 (+292.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TNXP is in a strong downtrend. Immediate support is located at $15.74, while resistance sits at $19.95. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: TNXP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (9th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $67.67 (+292.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$15.53 -
$17.91
Company Quality Score
55/100
(HOLD)
Options IV Signal
9th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
85.4%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 9th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.4%)
- BULLISH: Trading 292.5% below Wall St target ($67.67)
- CAUTION: Recommendation downgraded due to -5.9% 5-day decline
Fair Price Analysis
30-Day Fair Range
$15.53 -
$17.91
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$2.97
(17.2%)
Support & Resistance Levels
Support Level
$15.74
Resistance Level
$19.95
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.83
Wall Street Target
$67.67
(+292.5%)
Revenue Growth (YoY)
16.6%
Last updated: February 02, 2026 4:35 AM ET
Data refreshes hourly during market hours. Next update: 5:35 AM
Data refreshes hourly during market hours. Next update: 5:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNXP showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Carolyn E Taylor
BUY
418 shares
2025-08-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
